about
Role of Sphingolipids in the Pathobiology of Lung InflammationResveratrol: A potential challenger against gastric cancerCeramide-mediated macroautophagy involves inhibition of protein kinase B and up-regulation of beclin 1Dual effects of IGFBP-3 on endothelial cell apoptosis and survival: involvement of the sphingolipid signaling pathwaysDensitometric quantification of brain gangliosides separated by two-dimensional thin layer chromatography.Inhibitory effect of aureobasidin A on Toxoplasma gondiiAnti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis.Inhibition of ceramide biosynthesis preserves photoreceptor structure and function in a mouse model of retinitis pigmentosa.Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation.Resveratrol and breast cancer risk.Resveratrol as an anticancer nutrient: molecular basis, open questions and promises.Myriocin treatment of CF lung infection and inflammation: complex analyses for enigmatic lipids.Determination of the serine palmitoyl transferase inhibitor myriocin by electrospray and Q-trap mass spectrometry.Sphingolipid players in the leukemia arena.GM1-ganglioside-Triton X-100 mixed micelles: changes of micellar properties studied by laser-light scattering and enzymatic methods.Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena.Interactions of GM1 ganglioside with crude rat brain neuronal membranes.Strategies for comparing gene expression profiles from different microarray platforms: application to a case-control experiment.2-Acetyl-5-tetrahydroxybutyl imidazole (THI) protects 661W cells against oxidative stress.Inhibition of ceramide de novo synthesis by myriocin produces the double effect of reducing pathological inflammation and exerting antifungal activity against A. fumigatus airways infection.Natural grape extracts regulate colon cancer cells malignancy.Dihydroceramide delays cell cycle G1/S transition via activation of ER stress and induction of autophagy.Sphingosine mediates TNFα-induced lysosomal membrane permeabilization and ensuing programmed cell death in hepatoma cells.Antiproliferative activity and cell cycle analysis of 2-(3,5-dihydroxyphenyl)-6-hydroxybenzothiazole on MCF-7 breast and HCT-15 colon cancer cell lines.Antiproliferative activity of N6-isopentenyladenosine on MCF-7 breast cancer cells: cell cycle analysis and DNA-binding study.Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties.Resveratrol sensitization of DU145 prostate cancer cells to ionizing radiation is associated to ceramide increase.Synthesis of a resveratrol analogue with high ceramide-mediated proapoptotic activity on human breast cancer cells.Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling.Cytosolic gangliosides: occurrence in calf brain as ganglioside--protein complexes.In vitro anti-leukaemia activity of sphingosine kinase inhibitor.Metabolism of semisynthetic single-chain GM1 derivatives in cerebellar granule cells in culture.Naphthalene-fused (α-alkoxycarbonyl)methylene-γ-butyrolactones: antiproliferative activity and binding to bovine serum albumin and DNA.Increase in ceramide level alters the lysosomal targeting of cathepsin D prior to onset of apoptosis in HT-29 colon cancer cells.Extensive precursor-product relationship between gangliosides formed from exogenous glucosylceramide in rat liver.Dihydroceramide intracellular increase in response to resveratrol treatment mediates autophagy in gastric cancer cells.Inhibition of ceramide de novo synthesis as a postischemic strategy to reduce myocardial reperfusion injury.Cone survival and preservation of visual acuity in an animal model of retinal degeneration.Behavior of gangliosides on dialysis.Inhibitors of ceramide de novo biosynthesis rescue damages induced by cigarette smoke in airways epithelia.
P50
Q26771956-2D25001A-BA95-4B1C-8ABC-9DEACAC09AA2Q26784390-4CB1DBDE-5F69-4866-9ECA-77E1B28CFAD0Q28245694-B937BA77-9D9A-441C-9023-2883324E177CQ28271357-3F5DEF96-7906-4D1B-8F04-992081FEB13FQ33582868-B00B14E0-A370-4F8D-90E3-0BBA529FE37FQ33769976-28EDEABD-4243-487A-889B-4441793805DBQ33900765-ED0F75AE-5AA3-490C-9FC9-A4A6D062282BQ34276549-E4F96E58-BC8D-412D-AB9E-95A5ACBCF78FQ34484983-A7122099-AB38-4254-A27E-441F19C5F139Q34556179-B44986F8-5DA1-419C-AB51-96185392541EQ36206828-88E129C1-7E65-43D0-AA36-5F5DD7B8FC35Q36355889-8738FBB5-93CB-498A-A3FA-3F2E25087159Q36407230-E27F5FC4-BB84-4EB9-9EC0-247DB3240604Q36564062-17DA05B3-D53D-4C5B-A09F-BBE556E69C3FQ36656415-D661E5F3-F432-4C0B-A704-E8F193033AF9Q37971440-83DB5D5A-164E-4F99-89D3-6E79E6AB9DCCQ38356695-C12CA156-9520-4E8A-AD6A-6A2C2693E668Q38518575-3FB484E7-4158-4A01-B259-33761E8D001EQ38707720-F78CD0D9-2C25-4C06-9BAB-1141FF5FA921Q38790467-CC535C85-67A6-4974-960E-0A8E0882F8D7Q38907003-CC5C5BAE-8614-43F4-BE4F-2CB8A6D8048CQ39283168-8E4D9E45-1A14-4EF7-AF5A-427E91C172F5Q39372850-B7F6A4A7-C776-4E75-9BEB-7B5B09FC3CF3Q39570539-B7020BAA-2F0F-47F2-A5B4-12BE12901BA5Q39659158-7B714621-30C9-4750-9E9E-A72F25316608Q39664910-898AF54F-A85C-4C81-855C-AEA6C1870C04Q40166852-DBD6ABEC-CEBB-464D-B750-D94B334AD266Q40357881-E9691B23-3844-4B0A-8419-FE2BD067AB5DQ40625434-43A6BDE6-B8AA-4A6D-AEF6-18FC50115A35Q41690390-13E78616-1952-41A1-A829-2B58671459E5Q42445577-67F8230F-9510-4A00-A2B4-911DE58A08A1Q43570832-5B574E13-C758-461F-AEF9-02691A71B23CQ43741253-1E85C20D-1C05-483D-ADA2-9E7E9D3F10B8Q44131884-185B7E8F-E88D-49F4-B1D5-568D234DD0C7Q45858403-5944AAEA-7557-47DC-A0E5-68884D43FAADQ46036649-1E559D43-2566-43FB-A6B0-780607D3CAE4Q46608425-53BB5301-9FEB-4A08-AD53-3B03FEA65F9BQ46762692-659AB53D-1659-4982-AD10-CAF2CFC85427Q48146972-99073FE4-2E53-488D-A799-4527D8C436F5Q48275464-C3193F75-49E9-456D-ACCF-74C647A2A367
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Riccardo Ghidoni
@ast
Riccardo Ghidoni
@en
Riccardo Ghidoni
@es
Riccardo Ghidoni
@nl
type
label
Riccardo Ghidoni
@ast
Riccardo Ghidoni
@en
Riccardo Ghidoni
@es
Riccardo Ghidoni
@nl
prefLabel
Riccardo Ghidoni
@ast
Riccardo Ghidoni
@en
Riccardo Ghidoni
@es
Riccardo Ghidoni
@nl
P106
P1153
7005186568
P21
P31
P496
0000-0002-6300-5867